Olanzapine for the treatment of chronic refractory schizophrenia: a 12-month follow-up naturalistic study. [electronic resource]
Producer: 20030326Description: 1055-62 p. digitalISSN:- 0278-5846
- Antipsychotic Agents -- adverse effects
- Basal Ganglia Diseases -- chemically induced
- Benzodiazepines
- Body Weight -- drug effects
- Chronic Disease
- Drug Resistance
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Olanzapine
- Pirenzepine -- adverse effects
- Psychiatric Status Rating Scales
- Schizophrenia -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.